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ABSTRACT: 3-Fluoro- and trifluoromethylthio-piperidines rep-
resent important building blocks for discovery chemistry. We
report a simple and efficient method to access analogs of these
compounds that are armed with rich functionality allowing them to
be chemoselectively derivatized with high diastereocontrol.
F luorine-containing molecules exhibit a variety of usefulproperties in pharmaceuticals, agrochemicals, and materi-
als science.1−3 In particular, the introduction of a C−F bond
into a bioactive compound can have a dramatic impact on both
the physical and chemical properties of the molecule.4
Additionally, nitrogen heterocycles are one of the most highly
represented motifs within FDA approved small molecule drugs,
with the piperidine ring as the most prevalent example of this
class.5 Among other modifications of this cyclic amine, the
selective incorporation of a fluorine atom at the 3-position of
the piperidine scaffold has been demonstrated to be an
effective strategy to improve the pharmacological properties of
a number of biologically active compounds targeting SYK,6
CGRP,7 and MET kinase8 (Figure 1). In these cases, the
fluorine atom plays a key role in preventing metabolism, as well
as modulating the basicity of the nitrogen atom. 3-
Fluoropiperidines have also been investigated as radiotracers
for NR2B NMDA receptor visualization.9
In spite of the importance of 3-fluoropiperidine derivatives,
only a few general strategies exist to access these compounds.
The electrophilic fluorination of piperidone derived enol
equivalents has been reported,10 but this method faces
regioselectivity issues when applied to nonsymmetrical
scaffolds. The deoxofluorination of alkoxypiperidines has also
been reported, but these reactions require extensive
prefunctionalization and exhibit poor atom economy.11 A
particularly prevalent strategy relies on the intramolecular
aminofluorination of olefins using Pd-catalysis12 or hypervalent
iodine reagents.13 However, these methods commonly employ
strong oxidizing agents or rely on the use of stoichiometric
quantities of toxic13b or expensive reagents.13c A recent report
on the direct hydrogenation of fluorinated pyridines14 provides
a diastereoselective synthetic pathway for the synthesis of
fluoropiperidines, but the high H2 pressure required reduces
operational simplicity. We envisioned that our recently
reported [4 + 2] annulation strategy to N-heterocycles15
could offer a powerful route to 3-fluoropiperidines using
readily available α-fluoro-β-ketoester starting materials.16
Advantages of this method would include its highly modular
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Figure 1. Prominent bioactive 3-fluoropiperidines.
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nature, allowing for the rapid construction of the piperidine
core. Moreover, the heterocycle products contain orthogonal
functionality that would allow their elaboration to new
products through multiple vectors (Scheme 1).
We began our studies by investigating the allylation/
condensation reaction of readily available α-fluoro-β-ketoester
1a and cyclic carbamate 2 as shown in Scheme 2. Subjecting
this substrate to 5 mol % of Pd(dba)2 and 15 mol % of ligand
L1 followed by treatment of the intermediate with TFA led
smoothly to the desired 3-fluoropiperidine 4a in high yield
(Scheme 2a). Moreover, this product was also obtained in
comparable yield employing a one-pot procedure without
isolation of intermediate 3. To our delight, scaling up the
reaction to multigram quantities yielded 4a with similar results.
We then examined the applicability of this methodology to a
number of α-fluoro-β-ketoesters. Aryl substituted imines with
either electron-withdrawing or electron-donating groups at the
para-position on the aryl ring gave excellent yields (4b−f).
Substitution at other points on the aryl ring such as ortho-
methyl (4g) and naphthyl (4h) are also well tolerated. The
heterocyclic thiophenyl containing substrate 1i was also
converted into the corresponding piperidine imine 4i in 78%
yield. In addition to α-fluoro-β-ketoesters, numerous other
fluorinated nucleophiles could be employed in the allylation/
condensation sequence including α-fluoro-β-ketonitriles (4j),
α-fluoro-β-ketosulfones (4k), and α-fluoro-β-ketoamides (4l).
Unfortunately, however, α-fluoroketones bearing alkyl groups
were not transformed to the corresponding heterocycles, and a
complex mixture of products was instead produced.
Furthermore, this sequence could also be applied to alkyl
substituted α-fluoro-β-ketoesters in a regioselective manner
(Scheme 2b). Simple alkyl groups containing various levels of
substitution at the α-position (Me, 1°, 2°, and 3°) afforded the
piperidine imines 4n−4r in high yields. Finally, a derivative of
L-proline was evaluated, with 4s obtained in good yield and
with moderate diastereoselectivity. The excellent functional
group tolerance of this reaction sequence serves to highlight
the mild nature of this procedure.
We next turned our attention to demonstrating that the
functionalized 3-fluoropiperidines were versatile intermediates
for organic chemistry (Scheme 3). First, a chemoselective
reduction of 4a using NaBH(OAc)3 in acetic acid solvent
produced saturated piperidine 5 with high diastereoselectivity.
Subsequent protection of 5 using di-tert-butyl dicarbonate then
gave compound 6 in 88% yield, with the X-ray structure of 6
(CCDC 2063492) providing the relative configuration of the
major diastereoisomer obtained in this process. Interestingly, a
chemoselective reduction of the ester moiety was also achieved
using LiAlH4 to give 7 in moderate yield. A hydrolytic
Scheme 1. Synthetic Routes to 3-Fluoropiperidines
Scheme 2. Reaction Scopea
aReaction conditions: 1 (0.3 mmol), 2 (0.2 mmol), Pd(dba)2 (10 μmol, 5 mol %), L1 (30 μmol, 15 mol %), DCM (0.1 M), rt, 18 h under N2.
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decarboxylation using aq. HCl and heating afforded
fluoropiperidine 8, which could then be reduced using
NaBH4 to provide saturated piperidine 9 in 77% yield as a
single diastereoisomer following column chromatography.17
Notably, this decarboxylation circumvents the limitation
associated with the poor reactivity of α-fluoroketones in the
allylation/condensation cascade. Selective functionalization of
the exocyclic alkene is also possible; cross-metathesis produced
10 as a mixture of geometric isomers. The ability to selectively
functionalize each functional handle in piperidine imines 4
demonstrates their utility as synthetic intermediates.
The suitability of our method for accessing useful fluorinated
heterocycles suggested that it might be adapted to allow the
incorporation of trifluoromethylthio (SCF3) groups. In this
regard, and to the best of our knowledge, only two examples of
3-SCF3-substituted piperidines have been reported.
18 Due to
its electron-withdrawing nature and high lipophilicity, the
SCF3 moiety can significantly modulate the pharmacological
properties of bioactive compounds.19 Nevertheless, the
availability of synthetic methods that deliver saturated N-
trifluoromethyl-thiolated six-membered heterocycles is scarce,
and those that are documented suffer from limited substrate
scope.20
Our efforts to employ the [4 + 2] annelation sequence to α-
SCF3-ketones is summarized in Scheme 4. Aryl substituted
ketones proved to be excellent substrates for this trans-
formation, generating a range of 3-SCF3-substituted piper-
idines under mild conditions. Unfortunately, these products
proved to be unstable to chromatography, and so we used a
borohydride reduction step prior to isolation. Accordingly, 2-
aryl 3-trifluoromethylthio-piperidines 13a−g were isolated in
excellent yields over three steps, and with very high cis-
stereocontrol. X-ray crystal structure analysis of aryl substituted
products 13a (CCDC 2063487) and 13e (CCDC 2063489)
confirmed the relative stereochemistry of the major diaster-
eomer in these cases, and the stereochemistry of all other aryl-
substituted products was assigned by inference. Unfortunately,
however, 2-aryl-substituted ketones containing electron-with-
drawing groups (4-nitrophenyl and 4-trifluoromethylphenyl)
were found to decompose during the TFA-mediated
deprotection−condensation step. Finally, α-SCF3-propiophe-
none led to a more substituted analog 13h, while the potential
to access 2-alkyl piperidine products was confirmed in one
case, albeit in low yield.
In conclusion, we report that 3-fluoropiperidines bearing
orthogonal imine, ester, and alkene functionality can be readily
prepared and chemoselectively derivatized, providing a power-
ful approach to these important substructures. Moreover, this
method can be extended to provide the first general means to
incorporate the 3-trifluoromethylthio-group into piperidines,
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supplementary crystallographic data for this paper. These
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Scheme 3. Chemoselective Functionalization of 3-
Fluoropiperidine Iminesa
aReagents and conditions: (a) NaBH(OAc)3 (1.5 equiv), AcOH, rt,
18 h (90%); (b) Boc2O (2.0 equiv), Et3N (2.0 equiv), THF, rt, 18 h
(88%); (c) LiAlH4 (2.0 equiv), THF, rt, 3.5 h (50%); (d) aq. HCl (15
equiv), 100 °C, 1 h (quant.); (e) NaBH4 (2.0 equiv), MeOH, 0 °C to
rt, 18 h (77%); (f) Hoveyda−Grubbs second Gen. (5 mol %), pent-4-
en-1-yl acetate (3 equiv), DCM, 25 °C 18 h then reflux, 3 h (54%).
Scheme 4. Synthesis of 3-SCF3-Substituted Piperidines
a
aReagents and conditions: 11 (0.7 mmol), 2 (0.47 mmol), Pd(dba)2
(23 μmol, 5 mol %), L1 (70 μmol, 15 mol %), CH2Cl2 (0.1 M), RT,
18 h under N2.
bHeated at 40 °C.
Organic Letters pubs.acs.org/OrgLett Letter
https://doi.org/10.1021/acs.orglett.1c00752




Joseph P. A. Harrity − Department of Chemistry, University of
Sheffield, Sheffield S3 7HF, United Kingdom; orcid.org/
0000-0001-5038-5699; Email: j.harrity@sheffield.ac.uk
Authors
Víctor García-Vázquez − Department of Chemistry,
University of Sheffield, Sheffield S3 7HF, United Kingdom
Larry Hoteite − Department of Chemistry, University of
Sheffield, Sheffield S3 7HF, United Kingdom
Christopher P. Lakeland − Department of Chemistry,
University of Sheffield, Sheffield S3 7HF, United Kingdom
David W. Watson − Medicinal Chemistry, Oncology R&D
Research and Early Development, AstraZeneca Cambridge
Science Park, Cambridge CB4 0WG, United Kingdom
Complete contact information is available at:
https://pubs.acs.org/10.1021/acs.orglett.1c00752
Author Contributions
§V.G.V., L.H., and C.P.L. contributed equally to this work.
Notes
The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
We are grateful for support from AstraZeneca and the
European Funding Horizon 2020-MSCA (ITN-EJD CAT-
MEC 14/06-721223).
■ REFERENCES
(1) (a) Champagne, P. A.; Desroches, J.; Hamel, J.-D.; Vandamme,
M.; Paquin, J.-F. Monofluorination of Organic Compounds: 10 Years
of Innovation. Chem. Rev. 2015, 115, 9073−9174. (b) Fustero, S.;
Sedgwick, D. M.; Román, R.; Barrio, P. Recent advances in the
synthesis of functionalised monofluorinated compounds. Chem.
Commun. 2018, 54, 9706−9725. (c) Neumann, C. N.; Ritter, T.
Late Stage Fluorination: Fancy Novelty or Useful Tool. Angew. Chem.,
Int. Ed. 2015, 54, 3216−3221.
(2) (a) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur, V.
Fluorine in medicinal chemistry. Chem. Soc. Rev. 2008, 37, 320−330.
(b) Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.; Meanwell,
N. A. Aplications of Fluorine in Medicinal Chemistry. J. Med. Chem.
2015, 58, 8315−8359.
(3) Berger, R.; Resnati, G.; Metrangolo, P.; Weber, E.; Hulliger, J.
Organic fluorine compounds: a great opportunity to enhanced
materials properties. Chem. Soc. Rev. 2011, 40, 3496−3508.
(4) Müller, K.; Faeh, C.; Diederich, F. Fluorine in Pharmaceuticals:
Looking Beyond Intuition. Science 2007, 317, 1881−1886.
(5) Vitaku, E.; Smith, D. T.; Njardarson, J. T. Analysis of the
Structural Diversity, Substitution Patterns, and Frequency of Nitrogen
Heterocycles among U. S. FDA Approved Pharmaceuticals. J. Med.
Chem. 2014, 57, 10257−10274.
(6) (a) Curtis, N. R.; Davies, S. H.; Gray, M.; Leach, S. G.; McKie,
R. A.; Vernon, L. E.; Walkington, A. J. Asymmetric Fluorination
Approach to the Scalable Synthesis of a SYK Inhibitor. Org. Process
Res. Dev. 2015, 19, 865−871. (b) Mócsai, A.; Ruland, J.; Tybulewicz,
V. L. The SYK tyrosine kinase: a crucial player in diverse biological
functions. Nat. Rev. Immunol. 2010, 10, 387−402. (c) Tan, S.-L.; Liao,
C.; Lucas, M. C.; Stevenson, C.; DeMartino, J. A. Targeting the SYK-
BTK axis for the treatment of immunological and hematological
disorders: recent progress and therapeutic perspectives. Pharmacol.
Ther. 2013, 138, 294−309.
(7) Molinaro, C.; Phillips, E. M.; Xiang, B.; Milczek, E.; Shevlin, M.;
Balsells, J.; Ceglia, S.; Chen, J.; Chen, L.; Chen, Q.; Fei, Z.; Hoerrner,
S.; Qi, J.; de Lera Ruiz, M.; Tan, L.; Wan, B.; Yin, J. J. Org. Chem.
2019, 84, 8006−8018.
(8) Liederer, B. M.; Berezhkovskiy, L. M.; Dean, B. J.; Dinkel, V.;
Peng, J.; Merchant, M.; Plise, E. G.; Wong, H.; Liu, X. Precrinical
absortion, distribution, metabolism, excretion, and pharmacokinetic-
pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropi-
peridine 4-ylamino)-1H-pyrazolo[3,4-b]pyridin,4-yloxy)-3-fluoro-
phenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyrazine-4-carboxa-
mide, a novel MET Kinase inhibitor. Xenobiotica 2011, 41, 327−339.
(9) (a) Koudih, R.; Gilbert, G.; Dhilly, M.; Abbas, A.; Barré, L.;
Debruyne, D.; Sobrio, F. Synthesis and in vitro characterization of
trans and cis-[18F]-4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]-
3-fluoropiperidine-1-carboxylates as new potential PET radiotracer
candidates for the NR2B subtype N-methyl-D-aspartate receptor. Eur.
J. Med. Chem. 2012, 53, 408−415. (b) Koudih, R.; Gilbert, G.; Dhilly,
M.; Abbas, A.; Barré, L.; Debruyne, D.; Sobrio, F. Radiolabelling of
1,4-disubstituted 3-[18F]fluoropiperidines and its application to new
radiotracers for NR2B NMDA receptor visualization. Org. Biomol.
Chem. 2012, 10, 8493−8500.
(10) (a) Sun, A.; Lankin, D. C.; Hardcastle, K.; Snyder, J. P. 3-
Fluoropiperdines and N-Methyl-3-fluoropiperidinium salts: The
Persistence of an Axial Fluorine. Chem. - Eur. J. 2005, 11, 1579−
1591. (b) Shaw, S. J.; Goff, D. A.; Boralsky, L. A.; Irving, M.; Singh, R.
Enantioselective Synthesis of cis-3-Fluoropiperidin-4-ol, a Building
Block for Medicinal Chemistry. J. Org. Chem. 2013, 78, 8892−8897.
(c) Walpole, C.; Liu, Z.; Lee, E. E.; Yang, H.; Zhou, F.; Mackintosh,
N.; Sjogren, M.; Taylor, D.; Shen, J.; Batey, R. A. Diastereoselective
synthesis of fluorinated piperidine quinazoline spirocycles as iNOS
selective inhibitors. Tetrahedron Lett. 2012, 53, 2942−2947.
(11) (a) Goldberg, N. W.; Shen, X.; Li, J.; Ritter, T. AlkylFluor:
Deoxyfluorination of Alcohols. Org. Lett. 2016, 18, 6102−6104.
(b) Li, X.; Russell, R. K.; Spink, J.; Ballentine, S.; Teleha, C.; Branum,
S.; Wells, K.; Beauchamp, D.; Patch, R.; Huang, H.; Player, M.;
Murray, W. Process for Development for Scale-Up of a Novel 3,5-
Substituted Thiazolidine-2,4-dione Compound as a Potent Inhibitor
for Estroge-Related Receptor 1. Org. Process Res. Dev. 2014, 18, 321−
330.
(12) Wu, T.; Yin, G.; Liu, G. Palladium Catalyzed Intramolecular
Aminofluorination of Unactivated Alkenes. J. Am. Chem. Soc. 2009,
131, 16354−16355.
(13) (a) Serguchev, Y. A.; Ponomarenko, M. V.; Ignat’ev, N. V. Aza-
fluorocyclization of nitrogen-containing unsaturated compounds. J.
Fluorine Chem. 2016, 185, 1−16. (b) Vardelle, E.; Martin-Mingot, A.;
Jouannetaud, M.-P.; Bachmann, C.; Marrot, J.; Thibaudeau, S.
Substitution Effect on the Cyclization/Fluorination Reaction of N-
Dienes in Superacid. J. Org. Chem. 2009, 74, 6025−6034. (c) Kong,
W.; Feige, P.; de Haro, T.; Nevado, C. Regio- and Enantioselective
Aminofluorination of Alkenes. Angew. Chem., Int. Ed. 2013, 52, 2469−
2473.
(14) Nairoukh, Z.; Wollenburg, M.; Schlepphorst, C.; Bergander, K.;
Glorius, F. The Formation of all-cis-(multi)fluorinated piperidines by
a dearomatization-hydrogenation process. Nat. Chem. 2019, 11, 264−
270.
(15) Allen, B. D. W.; Connolly, M. J.; Harrity, J. P. A. A Pd-
Catalyzed Synthesis of Functionalized Piperidines. Chem. - Eur. J.
2016, 22, 13000−13003.
(16) Tang, L.; Yang, Z.; Jiao, J.; Cui, Y.; Zou, G.; Zhou, Q.; Zhou,
Y.; Rao, W.; Ma, X. Chemoselective Mono- and Difluorination of 1,3-
Dicarbonyl Compounds. J. Org. Chem. 2019, 84, 10449−10458.
(17) The stereochemical assignment of compound 9 was made on
the basis of 19F−1H coupling constants in the 19F NMR spectrum. See
Supporting Information for details.
(18) (a) Luo, J.; Liu, Y.; Zhao, X. Chiral Selenide-Catalyzed
Enantioselective Construction of Saturated Trifluoromethylthiolated
Azaheterocycles. Org. Lett. 2017, 19, 3434−3437. (b) Zhang, C.;
Wang, Y.; Song, Y.; Gao, H.; Sun, Y.; Sun, X.; Yang, Y.; He, M.; Yang,
Z.; Zhan, L.; Yu, Z.-X.; Rao, Y. Synthesis of quaternary carbon-
centered Benzoindolizidines via novel photoredox-catalyzed Alkene
Organic Letters pubs.acs.org/OrgLett Letter
https://doi.org/10.1021/acs.orglett.1c00752
Org. Lett. 2021, 23, 2811−2815
2814
aminoarylation: Facile access to Tylophorine and analogues. CCS
Chemistry 2019, 1, 352−364.
(19) (a) Manteau, B.; Pazenok, S.; Vors, J.-P.; Leroux, F. R. New
Trends in the chemistry of a-fluorinated ethers, thioethers, amines and
phosphines. J. Fluorine Chem. 2010, 131, 140−158. (b) Landelle, G.;
Panossian, A.; Leroux, F. Trifluoromethylethers and − thioethers as
tools for medicinal chemsitry and drug discovery. Curr. Top. Med.
Chem. 2014, 14, 941−951. (c) Barata-Vallejo, S.; Bonesi, S.; Postigo,
A. Late Stage trifluoromethylthiolation strategies for organic
compounds. Org. Biomol. Chem. 2016, 14, 7150−7182. (d) Xu, X.-
H.; Matsuzaki, K.; Shibata, N. Synthethic Methods for Compounds
having CF3-units on Carbon by Trifluoromethylation, Trifluorome-
thylthiolation, Triflylation and Related Reactions. Chem. Rev. 2015,
115, 731−764.
(20) (a) Hu, F.; Shao, X.; Zhu, D.; Lu, L.; Shen, Q. Silver-catalyzed
decarboxylative trifluoromethylthiolation of aliphatic carboxylic acids
in aqueous emulsion. Angew. Chem., Int. Ed. 2014, 53, 6105−6109.
(b) Candish, L.; Pitzer, L.; Gómez-Suárez, A.; Glorius, F. Visible
Light-Promoted Decarboxylative Di- and Trifluoromethylthiolation of
Alkyl Carboxylic Acids. Chem. - Eur. J. 2016, 22, 4753−4756.
(c) Shao, X.; Liu, T.; Lu, L.; Shen, Q. Copper-Catalyzed
Trifluoromethylthiolation of Primary and Secondary Alkylboronic
Acids. Org. Lett. 2014, 16, 4738−4741.
Organic Letters pubs.acs.org/OrgLett Letter
https://doi.org/10.1021/acs.orglett.1c00752
Org. Lett. 2021, 23, 2811−2815
2815
